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ABSTRACT
Chemoproteomic approaches to identify ligand-receptor inter-
actions have gained popularity. However, identifying transmem-
brane receptors remains challenging. A new trifunctional probe
to aid the nonbiased identification of such receptors was
developed and synthesized using a convenient seven-step
synthesis. This probe contained three functional groups: 1) an
N-hydroxysuccinimide ester for ligand-coupling through free
amines, 2) a diazirine moiety to capture the receptor of interest
upon irradiationwith UV light, and 3) a biotin groupwhich allowed
affinity purification of the final adduct using streptavidin.
The interaction between the G protein–coupled tachykinin
neurokinin 1 (NK1) receptor, expressed in an inducible manner,
and the peptidic ligand substance P was used as a test system.
Liquid chromatography–mass spectrometry analysis confirmed
successful coupling of the probe to substance P, while inositol
monophosphate accumulation assays demonstrated that cou-
pling of the probe did not interfere substantially with the
substance P–NK1 receptor interaction. Confocal microscopy
and western blotting provided evidence of the formation of a
covalent bond between the probe and the NK1 receptor upon
UV activation. As proof of concept, the probe was used in full
ligand-based receptor-capture experiments to identify the
substance P–binding receptor via liquid chromatography–
tandem mass spectrometry, resulting in the successful identi-
fication of only the NK1 receptor. This provides proof of concept
toward general utilization of this probe to define interactions
between ligands and previously unidentified plasma-membrane
receptors.
Introduction
Membrane proteins are vital components of drug discovery,
being targeted by some 60% of the currently marketed
therapeutic medicines, with roughly half of these interacting
with one or more members of the G protein–coupled receptor
(GPCR) superfamily (Overington et al., 2006; Hauser et al.,
2017; Santos et al., 2017). Identification of transmembrane
receptor targets of poorly characterized ligands can provide
new starting points for drug innovation, provide valuable
information about off-target effects, and enhance mechanistic
understanding of molecular pathways (Hopkins and Groom,
2002; Schirle and Jenkins, 2016).
Combining affinity chromatography with mass spectrome-
try (MS) is a popular chemoproteomic method that has been
used to identify intracellular ligand-receptor interactions
(Lenz et al., 2011); however, transmembrane receptors pos-
sess some unfavorable characteristics which hamper this
approach. For example, their hydrophobicity and high number
of post-translational modifications can result in aggregation
and loss of ligand-binding activity upon solubilization. More-
over, these receptors are regularly of low abundance, and their
interactions with ligands are often transient in nature,
making it challenging to maintain ligand-receptor interac-
tions throughout experiments (Wright, 2009; Helbig et al.,
2010; Savas et al., 2011; Vuckovic et al., 2013). Various groups
have endeavored to overcome these issues by developing
trifunctional probes either structurally based on a ligand of
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interest or capable of coupling to such a ligand (Frei et al.,
2012; Blex et al., 2017; Thomas et al., 2017; Tremblay andHill,
2017; Sobotzki et al., 2018). Apart from a ligand or ligand-
binding moiety, such probes must contain a receptor-capture
moiety, which enables formation of a covalent bond between
the probe and target receptor, and an affinity tag to assist with
receptor purification. The covalent bond formed between the
probe and target receptor prevents dissociation during such
studies. Moreover, as such a bond will stay intact during cell
lysis, it allows for ligand-receptor binding and receptor
capture to be performed on living cells, thus circumventing
binding issues faced following receptor solubilization.
One of the first trifunctional probes specifically designed to
identify membrane receptors on living cells is TRICEPS, a
potentially universal probe that is coupled to ligands of
interest through an amine-reactive N-hydroxysuccinimide
(NHS) ester (Frei et al., 2012). The ligand-probe adduct is
then used to capture and purify glycosylated target receptors,
as transplasma membrane proteins routinely become N-
glycosylated during transport from the endoplasmic reticu-
lum. Conceptually, the target can then be identified through
MS analysis. Although this elegant ligand-based receptor-
capture (LRC) strategy has resulted in successful identifica-
tion of certain membrane receptors (Li et al., 2016, 2018;
Ponda and Breslow, 2016), identification can only occur for
receptors carrying anN-linked glycan in close proximity to the
ligand-binding site. To overcome this glycan dependency,
others have recently developed ligand-derived probes harbor-
ing photoaffinity labels to capture target receptors (Blex et al.,
2017; Thomas et al., 2017). Nowadays such labels, which are
activated upon irradiation with UV light, are commonly used
to enhance capture of cytosolic receptors (Hatanaka, 2015).
Described herein is the design, synthesis, and evaluation of
a new trifunctional probe for LRC that combines the univer-
sality of a ligand-binding NHS ester with receptor capture
through a photoaffinity label. The interaction between the
tachykinin neurokinin 1 (NK1) receptor and substance P (SP)
was used as a test system. The NK1 receptor is a GPCR
belonging to the tachykinin family, and the undecapeptide SP
is its major and most potent endogenous ligand. Interaction
between the peptide and the NK1 receptor is associated with
various physiologic processes, including mitogenesis; wound
healing; and neuronal transmission related to pain, depres-
sion, stress, anxiety, and emesis (Garcia-Recio and Gascón,
2015). Initially, this systemwas used to investigate individual
steps in the LRC protocol, including ligand coupling, potential
interference of the probe on the ligand-receptor interaction,
and ability of the probe to covalently couple to the receptor.
Finally, it was also used in a full LRC experiment to provide a
proof of concept, demonstrating that this novel probe can be
used as a general tool to help identify target receptors for a
variety of ligands.
Materials and Methods
Unless otherwise stated, all (bio)chemicals and reagents were from
Sigma-Aldrich (Dorset, UK). Tissue culture reagents and buffers were
from Thermo Fisher Scientific (Paisley, UK). Molecular biology
enzymes and reagents were from New England BioLabs (Hitchin,
UK). Primers were ordered at Eurofins Genomics (Ebersberg, Ger-
many). For western blotting, the following primary antibodies were
used: mouse antitubulin (ab7291; 1:4000; Abcam, Cambridge, UK);
rabbit anti–hexa-histidine tag (6xHis, ab9108; 1:4000; Abcam); and
sheep anti–green fluorescent protein (produced in house). Secondary
antibodies (800CW goat anti-mouse, 680RD goat anti-mouse, 800CW
donkey anti-rabbit, and 800CW donkey anti-goat) and 680LT strepta-
vidin were purchased from LI-COR (Cambridge, UK) and were all
used at 1:10,000. Acetyl–norleucine–substance P (Ac-Nle-SP) and
probe 1 were synthesized as described here.
Chemical Synthesis
All chemicals were commercially obtained and usedwithout further
purification unless stated otherwise. Reactions involving air-sensitive
reagents and dry solvents were performed in flame-dried glassware
under nitrogen atmosphere. Reactions were monitored by thin layer
chromatography using plates with a UV fluorescent indicator (60 F254,
0.25 mm; Merck, Feltham, UK). Compounds were visualized either by
UV absorption or by dipping in molybdenum or a ninhydrin-based
stain, followed by heating. Column chromatography was performed
using silica gel 60 (35–70 mm; Merck) or with an Isolera One
purification system (Biotage, Ystrad Mynach, UK) and use of pre-
packed silica ULTRA SNAP cartridges (Biotage). An Alpha-2-4
lyophilizer (Christ, Osterode am Harz, Germany) equipped with a
high vacuum pump was used for lyophilization. All NMR spectra were
recorded using 400/500 NMR spectrometers (Bruker, Glasgow, UK).
Values of dH are given in parts permillion relative to an internal signal
of Me4Si (0.00 ppm) or the signal of CDCl3 (7.26 ppm). Values of dc are
given in parts permillion relative to the signal ofMe4Si (0.00 ppm), the
signal of CDCl3 (77.16 ppm), or the signal of (CD3)2SO (39.52 ppm). For
1HNMR spectra integration, multiplicity (s5 singlet, d5 doublet, t5
triplet, q 5 quartet, sept 5 septet, m 5 multiplet, br 5 broad, or a
combination of these), coupling constants [J (Hz)], and assignments
are also reported. For 13C NMR spectra, multiplicity and coupling
constants are reported where appropriate. High-resolution mass
spectrometry (HRMS) was performed by the analytical service of the
University of Glasgow, either on a MStation JMS-700 instrument
(Jeol, Welwyn Garden City, UK) using positive chemical ionization or
a positive ion impact, or on a micro TOFq High Resolution instrument
(Bruker) using positive ion electrospray. Analytical high-performance
liquid chromatography (HPLC) was performed on the Prominence
HPLC system (Shimadzu, Wolverton, UK) with a UV detector
operating at 214 and 254 nm using either a Phenomenex (Torrance,
CA) Gemini C18 column (110 Å, 5 mm, 250 4.60 mm) or a Dr. Maisch
(Ammerbuch, Germany) Reprosil Gold C18 column (200 Å, 5 mm,
250  4.6 mm) at a flow rate of 1 ml/min using a 40-minute protocol
(buffer A for 2minutes, a linear gradient of 0%–100%buffer B in buffer
A for 28minutes, buffer B for 2 minutes, a linear gradient of 100%–0%
buffer B in buffer A for 3minutes, and buffer A for 5minutes). Buffer A
consisted of H2O/MeCN 95:5 with 0.1% trifluoroacetic acid (TFA), and
buffer B consisted of MeCN/H2O 95:5 with 0.1% TFA. Liquid
chromatography–mass spectrometry (LC-MS) was carried out with
an LCQ Fleet quadrupole mass spectrometer (Thermo Fisher Scien-
tific) and an Ultimate 3000 LC (Dionex, Camberley, UK) with use of a
Dr. Maisch Reprosil Gold 120 C18 column (150 Å, 3 mm, 150  4 mm).
Buffers and protocols used were identical to those of analytical HPLC.
Synthesis Probe 1
For long-term storage, diazirine-containing products were pro-
tected from light. During synthesis, however, no extra care was taken
to avoid light, and no activation of the diazirine moiety was observed.
Compound 2: (9H-fluoren-9-yl)methyl tert-butyl (6-oxo-6-
(prop-2-yn-1-ylamino)hexane-1,5-diyl)(S)-dicarbamate
Fmoc-Lys(Boc)-OH (23.61 g, 50 mmol), Oxyma Pure Novabiochem
(10.48 g, 74 mmol) (Merck, Darmstadt, UK), and propargylamine
(3.4 ml, 53 mmol) were dissolved in dichloromethane (DCM; 1 l)
and cooled on ice. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
(EDC; 18.87 g, 98 mmol) was added, after which the (now turbid)
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mixture was stirred at room temperature (RT) for 40 minutes. The
reaction mixture was subsequently washed with H2O (500 ml, 3),
citric acid (1 M, 500 ml, 2), H2O (1 l), NaHCO3 (saturated, 500 ml,
2), and H2O (1 l). The organic layer was dried over MgSO4 and
concentrated under vacuum to yield a yellow solid (26.52 g, 95%).
Analytical data corresponded to previously reported data (Hartwig
and Hecht, 2010).
Compound 3: Tert-butyl (S)-(6-oxo-6-(prop-2-yn-1-
ylamino)-5-(3-(4-(3-(trifluoromethyl)-3H-diazirin-3-
yl)phenyl)propanamido)hexyl)carbamate
Compound 2 (748.4 mg, 1.5 mmol) was dissolved in piperidine/di-
methylformamide [DMF; 1:15 (v/v) 25ml], and themixturewas stirred
at RT. After 10minutes, themixture was concentrated under vacuum,
and the piperidine was removed by coevaporations with toluene. This
crude mixture was dissolved in 10 ml of DCM, and 3-(4-(3-(trifluor-
omethyl)-3H-diazirin-3-yl)phenyl)propanoic acid [304.0mg, 1.2 mmol,
synthesized as described before by Geurink et al. (2010)], hexafluor-
ophosphate benzotriazole tetramethyl uronium (448.1 mg, 1.2 mmol),
and N,N-diisopropylethylamine (DIPEA; 790 ml, 4.6 mmol) were
added. The total mixture was stirred for 2 hours at RT before it was
washed with H2O (50 ml), KHSO4 (1 M, 50 ml), and H2O (50 ml). The
organic layer was dried overMgSO4, concentrated under vacuum, and
purified by flash chromatography (DCM/MeOH 20:0→19:1), yielding a
white solid (556 mg, 91%).
Analytical Data. The analytical data for compound 3 were as
follows: 1H NMR (400 MHz, chloroform-d) d 7.26 (br s, 1H, NH), 7.20
(d, J5 8.4Hz, 2H, 2CAR-H), 7.09 (d, J5 8.0Hz, 2H, 2CAR-H), 6.73 (d,
J58.0Hz, 1H,NH), 4.79 (t,J56.0Hz, 1H,NH), 4.52 (td,J57.8, s5.8Hz,
1H, Lys-aCH), 4.06–3.85 (m, 2H, CH2C-CH), 3.08 (dd, J 5 11.9, 6.2 Hz,
2H, Lys-«CH2), 2.94 (td, J 5 7.6, 4.4 Hz, 2H, CH2CH2C
AR), 2.52 (t, J 5
7.7 Hz, 2H, CH2CH2C
AR), 2.20 (t, J 5 2.5 Hz, 1H, C-CH), 1.92–1.19 (m,
15H, Lys-b,g,dCH2 and Boc-CH3);
13C NMR (101 MHz, CDCl3) d 172.0,
171.6, 156.2, 142.5, 128.8, 127.1, 126.7, 122.16 (q,J5274.7Hz,CF3), 79.3,
77.3, 71.6, 52.7, 40.0, 37.4, 32.1, 31.1, 29.6, 29.1, 28.5 28.33 (q,J5 40.4Hz,
CN2-CF3), 22.5. Heteronuclear single quantum coherence spectroscopy
(HSQC) and correlation spectroscopy (COSY) spectra were in accordance
with assignments given earlier. C25H32F3N5O4 [M1Na]
1: 546.2299,
found: 546.2284.
Compound 4: (S)-4-oxo-4-((6-oxo-6-(prop-2-yn-1-ylamino)-
5-(2-(4-(3-(trifluoromethyl)-3H-diazirin-3-
yl)phenyl)acetamido)hexyl)amino)butanoic Acid
Compound 3 (554.2 mg, 1.1 mmol) was dissolved in DCM/TFA [1:1
(v/v) 60 ml] and stirred for 10 minutes before it was concentrated
under vacuum. The last traces of TFA were removed by three
coevaporations with toluene. The yellow solid that yielded was
dissolved inDMF (50ml), and succinic anhydride (128.4mg, 1.3mmol)
andDIPEA (880ml, 5.1mmol) were added. Themixturewas stirred for
45 minutes at RT, after which it was concentrated under vacuum. The
remaining solid was dissolved in DCM (100 ml) and extracted with
NaHCO3 (saturated, 150 ml, 2). The aqueous layers were acidified
with HCl (37%) and extracted with EtOAc (100 ml, 3). The organic
layerswere combined, dried overMgSO4, concentrated under vacuum,
and purified by flash chromatography (DCM/MeOH/AcOH, 19:1:0.2)
to yield the acid as a white solid (418 mg, 75% over two steps).
Analytical Data. The analytical data for compound 4 were as
follows: 1H NMR (400 MHz, methanol-d4) d 7.32 (d, J5 8.4 Hz, 2H, 2
CAR-H), 7.16 (d,J5 8.0Hz, 2H, 2CAR-H), 4.25 (dd, J5 8.7, 5.4Hz, 1H,
Lys-aCH), 4.05–3.79 (m, 2H, CH2C-CH), 3.14 (t, J5 7.0Hz, 2H, Lys-
«CH2),
2.94 (t, J5 7.7 Hz, 2H, CH2CH2C
AR), 2.66–2.50 (m, 5H, CH2CH2C
AR and
CH2CH2COOH),2.45 (t,J56.9Hz, 2H,CH2CH2COOH), 1.83–1.20 (m,6H,
Lys-b,g,dCH2);
13C NMR (101 MHz, MeOD) d 176.4, 174.8, 174.5, 174.0,
144.7, 130.3, 127.8, 127.7, 126.4 (q,J5274.0Hz,CF3), 80.5, 72.3, 54.5, 40.0,
38.0, 32.7, 32.3, 31.7, 30.5, 29.9, 29.6 (q, J5 39.7 Hz, CN2-CF3), 29.5, 24.0.
HSQC and COSY spectra were in accordance with assignments given
earlier. HRMS calculated for C24H28F3N5O5 [M1Na]
1: 546.1935, found:
546.1926.
Compound 5: 4-Oxo-4-(((S)-6-oxo-6-(((1-(15-oxo-19-
((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-
yl)-4,7,10-trioxa-14-azanonadecyl)-1H-1,2,3-triazol-4-
yl)methyl)amino)-5-(3-(4-(3-(trifluoromethyl)-3H-diazirin-3-
yl)phenyl)propanamido)hexyl)amino)butanoic Acid
Compound 4 (58.1 mg, 111 mmol) and biotin–polyethylene glycol
(PEG)–azide (65.1 mg, 138 mmol) [synthesized as described before by
Chambers et al. (2013)] were dissolved inMeOH (3ml). Next, aqueous
CuSO4 (10 mM, 2.8 ml) and aqueous sodium ascorbate (30 mg/ml,
335 ml) were added. The mixture was stirred under N2 atmosphere for
2 hours before it was concentrated under vacuum. The crude product
was purified by flash chromatography (DCM/MeOH/AcOH, 19:1:
0.2→16:4:0.2) to yield the biotinylated product as a white solid
(71 mg, 65%).
Analytical Data. The analytical data for compound 5 were as
follows: 1HNMR [500MHz, dimethylsulfoxide (DMSO)-d6] d 8.44 (br s,
1H, NH), 8.16 (br s, 1H, NH), 7.90–7.83 (m, 2H, NH, and triazole-CH),
7.76 (t, J5 5.7 Hz, 1H, NH), 7.35 (d, J5 8.0 Hz, 2H, 2 CAR-H), 7.17
(d, J 5 7.9 Hz, 2H, 2 CAR-H), 6.44 (s, 1H, NH), 6.37 (s, 1H, NH), 4.37
(t,J5 7.0Hz, 2H, PEG-CH2Ntriazole), 4.33–4.24 (m, 3H,NHCH2Ctriazole,
and biotin-SCH2CH), 4.24–4.14 (m, 1H, Lys- aCH), 4.13 (ddd, J5 7.3,
4.5, 1.8 Hz, 1H, biotin-SCHCH), 3.54–3.34 (m, 12H, 2 PEG-
OCH2CH2O, and 2 PEG-CH2CH2CH2O, overlapping with water
signal), 3.13–3.02 (m, 3H, biotin-SCH, and PEG-CH2NH), 2.96 (q, J5
6.5 Hz, 2H, Lys-«CH2), 2.88–2.78 [m, 3H, biotin-SCH2 (1H), and
CH2CH2C
AR], 2.58 [d, J 5 12.4 Hz, 1H, biotin-SCH2 (1H)], 2.50–2.40
(m, 2H, CH2CH2C
AR), 2.26 (s, 4H, CH2CH2COOH), 2.09–1.96 (m, 4H,
PEG-CH2CH2N
triazole, and biotin-aCH), 1.81–1.09 (m, 14H, Lys-b,g,dCH2,
biotin- b,g,dCH2, and PEG-CH2CH2NH);
13C NMR (126 MHz, DMSO) d
171.9, 171.2, 162.7, 144.8, 144.0, 129.3, 126.3, 125.1, 122.8, 122.0
(d, J5 275.5Hz,CF3), 69.8, 69.7, 69.6, 69.5, 68.1, 66.9, 61.1, 59.2, 55.4,
46.5, 40.0, 38.2, 36.2, 35.7, 35.2, 34.3, 31.6, 30.6, 30.0, 29.4, 28.7, 28.2,
28.0, 28.0 (d, J 5 39.8 Hz, CN2-CF3), 25.3, 22.7. HSQC, hetero-
nuclear multiple bond correlation, COSY and total correlated
spectroscopy spectra were in accordance with assignments given
earlier. HRMS calculated for C44H64F3N11O10S [M1Na]
1: 1018.4403,
found: 1018.4394.
Probe 1: 2,5-Dioxopyrrolidin-1-yl 4-oxo-4-(((S)-6-oxo-6-(((1-
(15-oxo-19-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-
d]imidazol-4-yl)-4,7,10-trioxa-14-azanonadecyl)-1H-1,2,3-
triazol-4-yl)methyl)amino)-5-(3-(4-(3-(trifluoromethyl)-3H-
diazirin-3-yl)phenyl)propanamido)hexyl)amino)butanoate
Compound 5 (27.5mg, 27.6 mmol) was dissolved in 3ml of dry DMF,
and NHS (33.5 mg, 291 mmol) and EDC (55.3 mg, 288 mmol) were
added. The mixture was stirred under N2 atmosphere for 2.5 hours,
after which it was concentrated under vacuum. The crude yellow oil
was triturated with ice-cold H2O (3 1 ml) to yield a white solid
(13.5 mg, 45%).
Analytical Data. LC-MS data are shown in Supplemental Fig. S1.
HRMS calculated for C48H67F3N12O12S [M1Na]
1: 1115.4566, found:
1115.4607.
Synthesis Ac-Nle-SP
Ac-Nle-SP was assembled by solid phase peptide synthesis on an
automatic Tribute-UV peptide synthesizer (Protein Technologies,
Manchester, UK) on a 0.25-mmol scale using Rink Amide resin
(0.24 mmol/g; Rapp Polymere, Tübingen, Germany). First, the resin
was allowed to swell in DMF (3 10 minutes). The Fmoc group was
then removed with a mix of piperidine/DMF [8 ml, 1:4 (v/v)] using
the Tribute-UV peptide synthesizer RV_top_UV_Xtend protocol,
followed by washes with DMF (5 30 seconds). Next, the correct
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Fmoc-protected amino acid was pre-activated for 2 min with HCTU
(4 eq) and DIPEA (8 eq) in DMF, before it was added to the resin and
shaken (20 min). The resin was washed with DMF (6 30 seconds),
after which Fmoc deprotection and coupling of the next amino acid
took place as before. After the coupling of the last amino acid, one
final Fmoc deprotection step took place. The resin was then
manually treated with Ac2O (250 ml, 2.3 mmol) and DIPEA
(185 ml, 1 mmol) in DMF (10 ml) for 30 minutes. The resin was
washed with DMF (5 30 seconds) and DCM (5 30 seconds) and
dried under high vacuum, and peptides were then cleaved and
deprotected in TFA/H2O/triisopropylsilane [10 ml, 95/2.5/2.5 (v/v/
v), 1 hour]. To precipitate the peptide, the TFA mixture was added
dropwise to an ice-cold solution of methyl tert-butyl ether/hexanes
[90 ml, 1:1 (v/v)]. After centrifugation (2000g, 5 minutes), the
supernatant was discarded and the peptide was washed twice more
with methyl tert-butyl ether/hexanes. The peptide was then
dissolved in tBuOH/H2O [15 ml, 1:1 (v/v)] and lyophilized to yield
a crude peptide. This crude was further purified using the Agilent
Technologies (Santa Clara, CA) 1260 Infinity LC System equipped
with a Gemini C18 column (110 Å,10 mm, 250  20 mm) using a
60-minute linear gradient of 0%–100% buffer B in buffer A at
12.5 ml/min. Fractions were autocollected based on the UV
measurements at 214 nm. Fractions containing pure peptide, as
assessed by analytical HPLC, were combined and lyophilized to
give Ac-Nle-SP with a 13% yield.
Analytical Data. For HPLC trace, see Supplemental Fig. S2.
LC-MS calculated for C66H102N18O14 [M12H]
21: 686.40, found: 686.50.
UV Activation of Probe 1
The free acid derivative of the probe (compound 5) was dissolved in
MeOH (1 mg/ml) and either kept in the dark or exposed to light of
365 nm for 15 minutes with a high-intensity UV lamp (SB-100p/FB;
Spectroline, Westbury, NY). Samples were analyzed using LC-MS.
Probe 1 Coupling to Ac-Nle-SP and Glycine
Probe 1 in DMSO (50 mM, 25 ml) was added to a solution of
Ac-Nle-SP in phosphate-buffered saline (PBS) (pH 8.2, 1.05 mM,
475 ml) to form Ac-Nle-SP-probe 8. The mixture was incubated for
1 hour at RT, during which time a precipitate formed. This was
redissolved by addition of 500 ml of DMSO, yielding a 0.5-mM solution
of 8 (Supplemental Fig. S3A). Glycine (Gly)-probe 9 was prepared in
a similar fashion using a solution of glycine in PBS (pH 8.2, 1 mg/ml,
475 ml) (Supplemental Fig. S3B). Although no precipitate formed,
this mixture was also diluted with 500 ml of DMSO. Moreover, to
keep the amount of probe, probe by-products, and DMSO between
Ac-Nle-SP-probe and Gly-probe equal, the volume of Gly-probe used
in all experiments was always identical to the volume of Ac-Nle-SP-
probe used. Both mixtures were stored at 220°C and went through
numerous freeze-thaw cycles over the span of a year without any
obvious loss of activity.
Generation of Flp-In T-REx 293 Cell Lines
Hemagglutinin-NK1-eGFP. A human NK1 construct in
pcDNA3.11 (TACR100000; cDNA Resource Center, Bloomsberg, CA)
was used as a polymerase chain reaction template. Primers were
designed to introduce a hemagglutinin (HA) epitope (YPYDVPDYA)
on the N terminus of the NK1 construct. Moreover, XhoI and
BamHI restriction sites were introduced at the 39 and 59 termini,
respectively. The primers used were 59 ACGTACGTACGTC-
TCGAGGCCACCATGTACCCCTATGACGTGCCCGATTACGCG-
GATAAC GTCCTCCCGGTGGACTCAGACCTCTCC 39 and 39
ACGTACGTACGTTGGATCCCGGGAGAGCACATTGGAGGAGAAG-
CTGAAGC 59. The resulting DNA fragment was subcloned between
the XhoI and BamHI sites of the pEGFP-N1 plasmid–harboring
monomeric Ala206Lys enhanced green fluorescent protein (eGFP), a
variant of eGFP that is less prone to dimerization (von Stetten et al.,
2012), resulting in an HA-NK1-eGFP construct. HA-NK1-eGFP was
excised from pEGFP-N1 with NheI and NotI. The NheI end was
blunted, and the fragment was subcloned into pcDNA5/FRT/TO
(Thermo Fisher Scientific) between EcoRV and NotI. This plasmid
was used in the Flp-In T-REx system to create cells inducibly
able to express HA-NK1-eGFP as described previously (Ward
et al., 2011).
HA-NK1-6xHis. Using NotI and AgeI, eGFP was excised from
the HA-NK1-eGFP construct in pcDNA5/FRT/TO. DNA encoding
a hexa-His tag, created by annealing the two primers 59 CCGGT-
CCACCATCACCATCACCATTAGGGCGCGCCGC 39 and 39 AGGTG-
GTAGTGGTAGTGGTAATCCCGCGCGGCGCCGG 59, was subcloned
into the same site, thereby creating an HA-NK1-6xHis construct. This
was used in theFlp-In T-REx system, as done earlier, to create cells able
to inducibly express HA-NK1-6xHis.
Cell Maintenance
Flp-In T-REx 293 cells able to express either HA-NK1-eGFP or
HA-NK1-6xHis upon addition of doxycycline (Dox) weremaintained in
complete Dulbecco’s modification of Eagle’s medium with glucose
(4500 mg/l) and sodium bicarbonate (without sodium pyruvate);
supplemented with 10% (v/v) fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 mg/ml), hygromycin (200 mg/ml), and blasticidin
(5 mg/ml) in a humidified 5% CO2 atmosphere at 37°C; and subcul-
tured every 3 days.
Dox Titration
Western Blotting. Flp-In T-REx 293 cells harboring HA-NK1-
eGFP or HA-NK1-6xHis were grown in poly-D-lysine–coated six-well
plates and incubated with various concentrations of Dox overnight.
Cells were harvested in radioimmunoprecipitation assay buffer
[50 mM HEPES (pH 7.4), 150 mM NaCl, 1% (v/v) Triton X-100, 0.5%
(w/v) sodium deoxycholate, 0.1% (w/v) SDS, 10 mMNaF, 5mMEDTA,
10 mM Na2HPO4, 5% (v/v) ethylene glycol, pH 7.3], passed through a
25-gauge needle (6), rotated for 45 minutes at 4°C, and centrifuged
for 10 minutes at 21,000g at 4°C to obtain cleared lysates. Lysates
were analyzed by western blotting.
Epifluorescence Quantification. Flp-In T-REx cells harboring
HA-NK1-eGFP were cultured on black clear-bottom 96-well plates
coated with poly-D-lysine. After induction with various concentrations
of Dox, the plates were incubated overnight. Cells were washed twice
withHanks’ balanced salt solution (HBSS) before theywere incubated
for 20 minutes at 37°C with 10 mg/ml Hoechst nuclear stain to enable
cell number determination. After two more washes with HBSS,
fluorescence was measured with a CLARIOstar plate reader (BMG
Labtech, Ortenberg, Germany). To quantify the Hoechst-stained
nuclei, an excitation wavelength of 355/20 nm and an emission
wavelength of 455/30 nm were used for eGFP 470/15 nm and
515/20 nm were used.
Inositol Phosphate Accumulation Assays
Flp-In T-REx 293 cells harboring HA-NK1-eGFP or HA-NK1-6xHis
were grown in T75 tissue culture flasks and induced by addition
of 100 ng/ml Dox overnight. Uninduced cells, grown in a similar
fashion, were used as negative controls. Inositol monophosphate (IP1)
experiments were performed using a homogeneous time-resolved
fluorescence-based detection kit (CisBio Bioassays, Codolet, France)
according to the manufacturer’s protocol. Cells were plated at
7500 cells/well into white, solid-bottom, 384-well plates with appro-
priate ligand concentrations present in the wells and incubated at
37°C for 2 hours. The reactions were stopped by the addition of the
supplied lysis buffer and supplemented with the homogeneous time-
resolved fluorescence reagents. Plates were incubated for 1–24 hours
at RT before the output was measured with a Pherastar FS plate
reader (BMG Labtech).
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Live-Cell Imaging Assays
Flp-In T-REx 293 cells harboring HA-NK1-eGFP were grown on
poly-D-lysine–coated coverslips and induced with 100 ng/ml Dox in
serum-free medium overnight. Uninduced cells, grown in a similar
fashion, were used as a negative control. All subsequent steps, apart
from the actual imaging, were performed on ice or at 4°C. HBSS was
used for all washes and dilutions. Cells were washed three times,
incubated with Ac-Nle-SP-probe 8 (1 mM) or Gly-probe 9 for 1 hour in
the dark, and washed an additional three times. For competition
experiments, Ac-Nle-SP (compound 7) (10 mM) was added, and cells
were incubated for 3 hours at 4°C in the dark, followed by three more
washes. The cells were exposed to light of 365 nm for 15minuteswith a
high-intensity UV lamp (SB-100p/FB; Spectroline). Cells were washed
three times and incubated with DyLight 594–conjugated streptavidin
(15 mg/ml; Vectorlabs, Peterborough, UK) for 30 minutes at RT in the
dark. After three final washes, cells were imaged using an 880 laser-
scanning confocal microscope (Zeiss, Cambridge, UK).
Simultaneous Dual-Color eGFP/DyLight 594 Live-Cell
Microscopy Imaging
A Zeiss 880 laser-scanning confocal microscope (invert configura-
tion), equipped with a 63 oil immersion Plan Apochromat objective
lens (numerical aperture 5 1.4), was used to acquire high-resolution,
12-bit-depth channel images (image size 5 512  512). Using the
single-track multiple-channel capability of the Zeiss Zen Black
software (version 2.3), HA-NK1-eGFP andDyLight 594–labeled ligand
were excited simultaneously at 488 and 561 nm, respectively. Well
separated spectral emission detection windows (495–555 nm for eGFP
and 600–700 nm for DyLight 594) were set up to ensure that the
emission signals elicited from each fluorophore were recorded without
any bleed through or time delay issues. The pinhole diameter was set
to 1 Airy unit, and frame averaging was set to 4 to minimize noise and
optimize signal collection. Bright field transmission images were
simultaneously detected along with the fluorescence images using
the dedicated transmitted light detector.
eGFP/DyLight 594 Colocalization Analysis
Each recorded channel image was exported into Metamorph
(version 7.8.13; Molecular Devices, San Jose, CA), and a green or red
look-up table was assigned to the eGFP and DyLight 594 channel
images, respectively. The total background level of autofluorescence
was subtracted (using a black-colored region adjacent to the fluoresc-
ing cell) from every matrix pixel used to form each 512  512 channel
image. To quantify the colocalization between HA-NK1-eGFP and
DyLight 594, green-red pixel intensity scatterplots were generated for
each image. Pearson correlation coefficient values were generated
from the generated scatter plots that described the degree to which
eGFP and DyLight 594 fluorescence at each homologous pixel varied
from a perfect positive correlation slope value of 1.0. This was done for
four representative images for each experimental group. Significant
statistical difference between the experimental groups was deter-
mined using analysis of variance with Tukey’s multiple comparison
test.
Receptor Capture by Ac-Nle-SP-Probe and Gly-Probe
Flp-In T-REx 293 cells harboring HA-NK1-6xHis were grown in a
10-cm dish and induced with 100 ng/ml Dox overnight. If needed for a
negative control, uninduced cells were grown in a similar fashion.
Cells were harvested using Versene. All subsequent steps were
performed on ice or at 4°C. Cells were resuspended in HBSS (600 ml)
supplemented with Ac-Nle-SP-probe 8 (1 mM) or Gly-probe 9. Cells
were incubated for 1 hour in the dark and under constant agitation.
Cells were spun down at 300g for 3 minutes and washed twice with
HBSS before being resuspended in HBSS (600 ml), transferred to a
12-well plate, and exposed to light of 365 nm for 15 minutes (SB-
100p/FB; Spectroline). Cells were transferred back to a 15-ml Falcon
tube, centrifuged at 3200g for 5 minutes, and washed twice with PBS
before they were frozen at 220°C for at least an hour. From there,
all buffers were supplemented with cOmplete EDTA-free Protease
Inhibitor Cocktail (Roche, Burgess Hill, UK). Frozen cell pellets were
resuspended in PBS buffer (500 ml), passed through a 25-gauge needle
(10), homogenized using a glass on a Teflon homogenizer (50), and
again passed through a needle (10). To remove cell debris, the
mixture was centrifuged at 200g for 5 minutes, after which the
supernatant was centrifuged at 50,000g for 30 minutes. The pellets
were resuspended in PBS supplemented with 1% (v/v) NP40 (150 ml),
after which the samples were rotated for 1 hour. The lysates were then
centrifuged at 21,000g for 10 minutes to get rid of any nonsolubilized
material. Lysates were analyzed by western blotting or used for the
full LRC experiment.
Western Blotting
Lysates of the Dox titration and receptor-capture experiments were
analyzed through western blotting. A bicinchoninic assay (Expedeon,
Cambridge, UK) was used according to the manufacturer’s protocol to
determine and equalize the protein concentrations of the samples.
SDS-PAGE sample buffer was added to the samples, and they were
heated to 65°C for 5 minutes. Ten to 20 mg of protein per sample was
loaded into wells of 4%–12% BisTris precast NuPAGE or BOLT gels
(Thermo Fisher Scientific) and subjected to SDS-PAGE in NuPAGE
or BOLT MOPS SDS running buffer (Thermo Fisher Scientific). The
proteins were then electrophoretically transferred to a nitrocellulose
membrane, which was blocked in PBS blocking buffer (LI-COR) and
subsequently probed for HA-NK1-eGFP, HA-NK1-6xHis, tubulin,
and/or biotin using the appropriate primary and secondary antibodies,
or streptavidin diluted in PBS blocking buffer (LI-COR) supplemented
with 0.2%Tween 20. AnOdyssey Scanner (LI-COR) was used to image
the membranes.
Full Ligand-Based Receptor-Capture Experiment
For the full LRC experiment, receptor capture took place as
described earlier, with the exception that five confluent T150 flasks
were used, buffer quantities were multiplied by 10, and UV activation
was performed in a 10-cm dish. All subsequent steps were performed
on ice or at 4°C, and all buffers were supplemented with cOmplete
EDTA-free Protease Inhibitor Cocktail (Roche). Lysates were added to
Pierce Streptavidin Agarose beads (250 ml; Thermo Fisher Scientific),
and the total volume was up to 3 ml using PBS supplemented with 1%
(v/v) NP40. The beads were incubated overnight before being washed
four times with radioimmunoprecipitation assay buffer, four times
with PBS supplemented with 880mMNaCl, and four times with PBS.
Beads were frozen at 280°C until they were analyzed by liquid
chromatography–tandem mass spectrometry (LC-MS/MS). For each
condition, three biologic repeats were performed.
LC-MS/MS Analysis
Proteomics was carried out by the University of Leicester Proteo-
mics Facility (Protein Nucleic Acid Chemistry Laboratory, University
of Leicester, Leicester, UK). The streptavidin-conjugated beads were
resuspended by gentle mixing and transferred to a 30,000–molecular
weight cutoff filtration unit (Vivacon 500; Satorius, Göttingen,
Germany). Excess liquid was removed by spinning at 14,000g for
15 minutes. The beads were then resuspended a total of two times in
200 ml of freshly prepared 8 M urea in 0.1 M Tris/HCl (pH 8.5) and
spun at 14,000g for 15 minutes, discarding the flow through solution.
Reduction was carried out by addition of 100 ml of 5 mM dithiothreitol
solution for 30minutes at 60°C. After cooling, samples were incubated
with addition of 100ml of 50mM iodoacetamide solution for 30minutes
at RT in the dark. After incubation, solutions were removed by
spinning at 14,000g for 15 minutes. Beads were then resuspended a
total of two times in 100 ml of 8 M urea in 0.1 M Tris/HCl (pH 8.5) and
spun at 14,000g for 15 minutes, discarding the flow through solution.
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Fig. 1. A flowchart of ligand-based receptor capture and the synthesis of probe 1. (A) To initiate ligand-based receptor capture, the probe is first coupled
to the ligand of interest (top of scheme) or a control ligand (glycine, bottom of scheme), after which the adduct is added to cells potentially expressing a
target receptor. After an appropriate incubation time, duringwhich the ligand binds the receptor, cells are washed to rinse away unbound probe. Cells are
then exposed to UV light to activate the diazirine moiety which captures the receptor. Cells are lysed, and lysates are added to streptavidin beads.
Captured proteins are digested on the beadswith trypsin, and released peptides are analyzed usingmass spectrometry. Comparison between the proteins
identified for ligand-treated and glycine-treated cells should reveal the ligand-binding receptor. (B) Synthesis of probe 1. HBTU, hexafluorophosphate
benzotriazole tetramethyl uronium.
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Beads were then resuspended twice in 100 ml of 50 mM triethylam-
monium bicarbonate and spun at 14,000g for 15 minutes, discarding
the flow through solution. Just prior to use, lyophilized trypsin was
resuspended in 50 mM triethylammonium bicarbonate, and 5 mg was
added to each sample. Digestion took place overnight at 37°C in a
humidified chamber. Filter units were transferred to a clean collection
tube, and samples were spun down for 10 minutes at 14,000g. A
further 40 ml of 50 mM triethylammonium bicarbonate was added to
beads, and samples were spun again for 10 minutes at 14,000g. The
samples were concentrated to approximately 20-ml volume in a
SpeedVac centrifuge (Thermofisher Scientific, Paisley, UK), and
digests were then acidified with formic acid (final concentration
Fig. 2. Structures ofAc-Nle-SP (A),Ac-Nle-SP-probe (B),
and Gly-probe (C).
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0.1%). LC-MS/MS was carried out using an RSLCnano HPLC system
(Dionex) and an LTQ-Orbitrap-Velos mass spectrometer (Thermo
Fisher Scientific). Samples were loaded at a high flow rate onto a
reverse-phase trap column (0.3 mm i.d.  1 mm) containing 5 mmC18
300 Å Acclaim PepMap medium (Dionex) maintained at a tempera-
ture of 37°C. The loading buffer was 0.1% formic acid/0.05% trifluoro-
acetic acid/2% acetonitrile. Peptides were eluted from the trap column
at a flow rate of 0.3 ml/min and through a reverse-phase capillary
column (75 mm i.d.  250 mm) containing Symmetry C18 100 Å
medium (Waters, Elstree, UK) that was manufactured in house using
a high-pressure packing device (Proxeon Biosystems, Odense, Den-
mark). The output from the column was sprayed directly into the
nanospray ion source of the LTQ-Orbitrap-Velos mass spectrometer.
The LTQ-Orbitrap-Velos mass spectrometer was set to acquire a
1 microscan Fourier transform (FT) MS scan event at 60000 resolu-
tion over the m/z range 300-2000 Da in positive ion mode. The
maximum injection time for MS was 500 ms, and the AGC target
setting was 1e6. Accurate calibration of the FTMS scan was achieved
using a background ion lock mass for C6H10O14S3 (401.922718 Da).
Subsequently, up to 10 data-dependent higher energy collisional
dissociation MS/MS were triggered from the FTMS scan. The
isolation width was 2.0 Da, and normalized collision energy was
42.5. Dynamic exclusion was enabled. The maximum injection time
for MS/MS was 250 ms, and the AGC target setting was 5e4. The
.raw data file obtained from each LC-MS/MS acquisition was
processed using Proteome Discoverer (version 1.4; Thermo Fisher
Scientific), searching each file in turn using Mascot (version 2.2.04;
Matrix Science Ltd., London, UK) (Perkins et al., 1999) against the
human reference proteome downloaded from UniProtKB (proteome
identifier: UP000005640; UniProt Consortium, 2010). The peptide
tolerance was set to 5 ppm, and the MS/MS tolerance was set to 0.05
Da. Fixed modifications were set as carbamidomethyl (C) with vari-
able modification of oxidation (M) and phosphorylation (S, T, and Y).
Trypsin was selected as the enzyme, and up to three missed cleavages
were allowed. A decoy database search was performed. The output
from Proteome Discoverer was further processed using Scaffold Q1S
(version 4.0.5; Proteome Software, Portland, OR) (Searle, 2010). Upon
import, the datawere searchedusingX!Tandem (TheGlobal Proteome
Machine Organization) (Craig and Beavis, 2004). PeptideProphet
(Keller et al., 2002) andProteinProphet (Institute for SystemsBiology,
Seattle, WA) (Nesvizhskii et al., 2003) probability thresholds of 95%
were calculated from the decoy searches, and Scaffold was used to
calculate an improved 95% peptide and protein probability threshold
on the data from the two different search algorithms. Protein
identifications were accepted if they contained at least three identified
peptides.
Results
Design and Synthesis of the Probe. A probe for ligand-
based receptor capture should permit the attachment of a
ligand, enable receptor capture, and allow enrichment for
identification via, for example, MS analysis (Fig. 1A). Similar
Fig. 3. Doxycycline-dependent expression of HA-NK1-eGFP and HA-NK1-6xHis. Flp-In T-REx 293 cells expressed HA-NK1-eGFP (A–C) or HA-NK1-
6xHis (D) following induction by treatment with Dox. (A) Expression of HA-NK1-eGFP following overnight treatment with various concentrations of Dox
was visualized by immunoblotting with anti–green fluorescent protein after cell lysates were resolved with SDS-PAGE and transferred to blotting
membrane. An antitubulin antiserum provided a loading control. (B) Expression of HA-NK1-eGFP following overnight treatment of cells with various
concentrations of Dox and treatment with Hoechst nuclear stain (10 mg/ml, 30 minutes) was quantified with a microplate reader by measuring
fluorescence of eGFP and the Hoechst-stained nuclei. (C) Cells as aforementioned were treated in the absence (left panel) or presence of Dox (100 ng/ml;
right panel) overnight and imaged using a confocal microscope while HA-NK1-eGFP was excited. (D) Expression of HA-NK1-6xHis following overnight
treatment with various concentrations of Dox was visualized by immunoblotting with anti-6xHis after cell lysates were resolved with SDS-PAGE and
transferred to blotting membrane. As in (A), an antitubulin antiserum provided a loading control.
A Ligand-Based Receptor-Capture Probe Targeting GPCRs 203
 at A
SPET Journals on A
ugust 2, 2019
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
to other probes, an NHS ester was chosen to attach the ligand
to the probe. Under physiologic conditions, the NHS ester
reacts with primary amines, present in peptide and protein
ligands, to yield amide bonds (Anderson et al., 1963; Mädler
et al., 2009). To enable receptor capture, a photoaffinity label
was introduced. Irradiation of such labels results in covalent
coupling to nearby molecules (Sumranjit and Chung, 2013). A
diazirine moiety was chosen over other photoaffinity labels
due to its reported short activation time, high stability, and
low background photo cross-linking (Kleiner et al., 2017; Hill
and Robertson, 2018). For enrichment of the captured
receptor(s) after cell lysis, a biotin moiety was incorporated
into the probe. The required functional groups were intro-
duced into a trifunctional molecular scaffold based on lysine,
creating probe 1, which can be used for ligand-based receptor
capture (Fig. 1). Probe 1 was conveniently synthesized in
seven steps from Fmoc-N-«-Boc-lysine with an overall yield of
19% (Fig. 1B). The synthesis started with the coupling of
propargylamine to the free carboxylic acid, creating an alkyne
handle in amide 2. This was followed by Fmoc deprotection
and coupling of the photoaffinity label 3-{4-[3-(trifluoro-
methyl)-3H-diazirin-3-yl]phenyl}propanoic acid, leading to
compound 3 (Geurink et al., 2010). After Boc-deprotection,
succinic anhydride was used to incorporate a carboxylic acid
moiety, thereby affording compound 4. Addition of biotin-
PEG-azide via copper(I)-catalyzed azide alkyne cycloaddition
(CuAAC) resulted in the formation of compound 5, which was
activatedwith anNHS ester to yield the final product, probe 1.
Before proceeding to the biologic evaluation, it was confirmed
that UV irradiation of the probe did indeed activate the
diazirine moiety followed by insertion of the resulting carbene
into nearby molecules (Supplemental Fig. S4).
Synthesis of Substance P and Coupling to the
Probe. The NK1 receptor and its ligand SP were chosen as
a test system. A slightly modified version of SP (Ac-Nle-SP), in
which the C-terminal methionine residue was replaced with a
norleucine (Nle) residue and the N terminus was capped with
an acetyl (Ac) group to leave only one free amine available, was
synthesized using solid phase peptide synthesis (Fig. 2A;
Supplemental Fig. S2). Addition of probe 1 (2.5 eq) to
Ac-Nle-SP in PBS (pH 8.2) resulted in coupling of Ac-Nle-SP
to probe 1, yielding Ac-Nle-SP-probe 8, while no free
Ac-Nle-SP remained (Fig. 2B; Supplemental Fig. S3A). The
remainder of the probe either hydrolyzed back to the free acid
5 or formed cyclization product 6 (Supplemental Fig. S3A). To
function as a negative control, probe 1 was also coupled to
glycine, resulting in a similar mixture of Gly-probe 9 (Fig. 2C),
and hydrolyzed probe 5 and cyclization product 6 (Supple-
mental Fig. S3B).
Generation of NK1-Expressing Cell Lines. The Flp-In
T-REx 293 system was used to create cell lines designed to
allow inducible expression of a receptor of interest upon
addition of the antibiotic Dox (Fig. 3). In the first of these,
an NK1 receptor construct was generated in which the HA
epitope tag (amino acid sequence YPYDVPDYA) was engi-
neered into the extracellular N-terminal domain, and eGFP
was added in frame with the intracellular C-terminal tail of
the receptor (HA-NK1-eGFP). In a second iteration, eGFP was
replaced with a hexa-histidine tag (HA-NK1-6xHis) to facili-
tate detection using an anti-6xHis antiserum.
Binding of Ac-Nle-SP-Probe to the NK1 Receptor.
TheNK1 receptor interacts with G proteins of theGq class, and
this results in the hydrolysis of phosphatidylinositol 4,5-
bisphosphate. To confirm that Ac-Nle-SP-probe retained
affinity for the receptor, accumulation of the IP1 end
products of this reaction was assessed in Flp-In T-REx
293 cells that had been treated with Dox to induce expres-
sion of either HA-NK1-eGFP or HA-NK1-6xHis. These
studies showed that although the potency of Ac-Nle-SP-
probe was reduced by a factor of between 4- and 8-fold
compared with free Ac-Nle-SP, it retained binding and
agonism at the receptor (Fig. 4). Control experiments
confirmed that no response was obtained in cells not
induced to express the NK1 receptor constructs or in cells
treated with the Gly-probe.
To study the binding of Ac-Nle-SP-probe to the NK1 receptor
directly, confocal microscopy was performed on HA-NK1-
eGFP–expressing cells. The eGFP component of this recep-
tor construct can be visualized directly when the receptor is
induced, and indeed, cell surface localization of the expressed
receptor was clearly observed in Dox-induced cells but not
in uninduced cells (Fig. 5, upper panels). Following treatment
of cells with 1 mM Ac-Nle-SP-probe for 1 hour at 4°C, after
which cells were washed and exposed to UV light for
15 minutes, DyLight 594–conjugated streptavidin, which
interacts with the biotin component of the probe, was used
to visualize binding of Ac-Nle-SP-probe to HA-NK1-eGFP (Fig.
5, middle panels). This was obvious only when the receptor
was expressed and was not replicated when Gly-probe was
used (Fig. 5, middle panels). Merging of the images showed
colocalization at the level of light microscopy of the eGFP-
containing receptor and the DyLight 594–labeled probe
(Fig. 5, lower panels).
Fig. 4. Ac-Nle-SP-probe activates the NK1 receptor constructs. IP1
accumulation was assessed in both Dox-induced and uninduced Flp-In
T-REx 293 cells harboring either the HA-NK1-eGFP (A) or the HA-NK1-
6xHis (B) construct. The Ac-Nle-SP-probe was clearly active, although less
potent that native Ac-Nle-SP. Data are means 6 S.D. pooled from n =
3 independent experiments, each performed in triplicate.
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NK1 Receptor Capture by Ac-Nle-SP-Probe. To con-
firm that the observed interaction between probe 1 and
HA-NK1-eGFP was indeed covalent and not simply a reflection
of a slow off-rate of Ac-Nle-SP-probe from the receptor following
initial binding, competition experiments were performed. As
before, cells expressing HA-NK1-eGFP were treated with
Ac-Nle-SP-probe followed by irradiation with UV light. Now,
however, before adding the DyLight 594–conjugated streptavi-
din to visualize probe binding to the receptor, cells were
incubated with excess free Ac-Nle-SP. Treatment with free
ligand did not result in reduction of colocalization between the
probe and the receptor for cells exposed to UV light (Fig. 6,
samples 1 vs. 3). By contrast, when cells weremaintained in the
dark, there was a significant (P # 0.001) reduction in colocal-
ization (Fig. 6, samples 2 vs. 4), indicating partial dissociation of
Ac-Nle-SP-probe from the receptor over this time period. This
suggests that UV activation did indeed induce covalent linkage
between the probe and the NK1 receptor, and although
dissociation of Ac-Nle-SP-probe from the receptor in the
absence of cross-linking was slow, it did occur.
To further confirmUV-induced formation of a covalent bond
between the photoaffinity probe and HA-NK1-eGFP, western
blotting was performed. Since Flp-In T-REx 293 cells consti-
tutively express a number of endogenously biotinylated pro-
teins, which unfortunately migrated at the same molecular
mass on SDS-PAGE gels as the HA-NK1-eGFP receptor,
these experiments were performed on cells expressing the
HA-NK1-6xHis receptor construct, which is predicted to have
a substantially lower molecular mass (by some 27 kDa).
FollowingDox-induced expression of HA-NK1-6xHis, cells were
treated with Ac-Nle-SP-probe, washed, and exposed to UV
light. Cells were then lysed and membrane preparations
collected. Streptavidin detection confirmed the presence of a
biotinylated protein of the samemobility as the HA-NK1-6xHis
receptor in UV-irradiated samples treated with Ac-Nle-SP-
probe (Fig. 7, sample 2) but not in samples treated with Gly-
probe (Fig. 7, sample 3), nor in samples thatwere not exposed to
UV light (Fig. 7, sample 4) or in samples not expressing theNK1
receptor (Fig. 7, sample 5). This confirmed that a covalent bond
was indeed formed between Ac-Nle-SP-probe and the NK1
receptor but not between Gly-probe and the receptor.
Ligand-Based Receptor Capture Using Ac-Nle-SP-
Probe. Confidence in the ability to selectively label the NK1
receptor now allowed attempts to identify the covalently
captured receptor in a nonbiased manner via ligand-based
receptor capture and MS according to the procedure depicted
in Fig. 1. After treatment of cells expressing HA-NK1-6xHis
with either Ac-Nle-SP-probe or Gly-probe followed by expo-
sure to UV, membrane preparations were obtained, detergent
solubilized, and added to streptavidin-coated beads. An “on-
bead” trypsin digest was performed, and resulting peptides
were analyzed using LC-MS/MS. This resulted in a total list of
49 identified human proteins, 48 of which were identified
in both Gly-probe- and Ac-Nle-SP-probe–treated samples
(Fig. 8A; SupplementalMaterial). This groupmostly consisted
of endogenously biotinylated proteins, including carboxylases
Fig. 5. Ac-Nle-SP-probe binds to the NK1 receptor constructs at the cell surface. Dox-induced or uninduced Flp-In T-REx 293 cells harboring HA-NK1-
eGFP were treated with Ac-Nle-SP-probe or Gly-probe (1 mM at 4°C for 1 hour) before exposure to UV light (15 minutes) and were then treated with
DyLight 594-conjugated streptavidin before they were imaged using a confocal microscope. HA-NK1-eGFP and the DyLight 594–labeled probe were
excited simultaneously at 488 nm (upper panels) and 561 nm (middle panels), respectively. Colocalization between the receptor and the probe was
visualized (yellow color; lower panels). The bright field image demonstrates that cells were present in the uninduced 2Dox panels.
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and common contaminants such as keratin. The NK1 receptor
(UniProt identifier P25103), which was recovered as five
distinct peptide fragments (Fig. 8B; Table 1), was the only
protein identified in Ac-Nle-SP-probe- but not in Gly-probe–
treated samples. Moreover, apart from NK1, none of the other
protein hits showed significant differences (P# 0.05) in either
total spectrum count or total ion current between the samples,
illustrating the specificity of the system and probe developed
(Supplemental Material).
Discussion
Herein, the development, synthesis, and evaluation of a new
trifunctional probe for ligand-based receptor capture have
Fig. 6. Ac-Nle-SP-probe covalently captures NK1 receptor
constructs upon UV activation. (A) Dox-induced Flp-In
T-REx 293 cells expressing HA-NK1-eGFP were treated
with Ac-Nle-SP-probe (1 mM at 4°C for 1 hour) before they
were activated with UV light for 15 minutes (samples 1 and
3) or kept in the dark (samples 2 and 4). Cells were then
either treated immediately with DyLight 594–conjugated
streptavidin (samples 1 to 2) or were first exposed to
Ac-Nle-SP (10 mM at 4°C for 3 hours) (samples 3 to 4). They
were then imaged using a confocal microscope. HA-NK1-
eGFP and the DyLight 594–labeled probe were excited
simultaneously at 488 nm (upper panels) and 561 nm
(middle panels), respectively. Colocalization between the
receptor and the probe was visualized (yellow color; lower
panels). (B) Colocalization was quantified by generating
green-red pixel intensity scatterplots for each pixel and
determining the Pearson correlation coefficient for four
representative images for each condition. Data are means
+ S.D. Significant statistical difference was determined
using analysis of variance with Tukey’s multiple compari-
son test (***P # 0.001).
Fig. 7. Detection of Ac-Nle-SP-probe NK1 receptor interactions. Dox-induced (lanes 1–4) or uninduced (lane 5) Flp-In T-REx 293 cells harboring
HA-NK1-6xHis were treated with either Ac-Nle-SP-probe (lanes 2, 4, and 5) or Gly-probe (lane 3) and then exposed to UV light (lanes 1–3 and 5) or
maintained in the dark (lane 4). Following cell lysis, membrane preparations were generated and resolved by SDS-PAGE. These were immunoblotted
with an anti-6xHis antiserum (left panel) or streptavidin (center panel). Merging of these two images and pseudocolor labeling identifies the receptor-
probe complex as yellow (right panel).
206 Müskens et al.
 at A
SPET Journals on A
ugust 2, 2019
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
been documented. This probe uses a diazirine photoaffinity
label to capture nearby target receptors. This has several
advantages over other capture techniques. First, all receptors
with an extracellular domain can be captured in intact cells by
such a photo-reactive group. This is in contrast to, for example,
the protected hydrazine group used in TRICEPS, which can
only capture receptors that areN-glycosylated in proximity to
the ligand-binding site (Frei et al., 2012). Second, a washing
step after ligand-receptor binding but before receptor capture
can be introduced, thus reducing nonspecific binding and
background labeling by the probe. Third, as these groups are
very stable in the absence of light, the ligand can be coupled to
the probe and the complex can be stored, limiting the need to
synthesize new batches of the probe for each experimental
run. For affinity purification, a biotinmoiety was incorporated
into the probe. Biotin is the most widely used affinity tag due
to its high-affinity binding to streptavidin (Hermanson, 2013);
however, a new trend in the development of cytosolic probes
has emerged recently. This involves the incorporation of an
alkyne or azide handle into the probe instead of the bulky
biotin group, which would hinder cell entrance of the probe.
CuAAC can then be used to couple biotin, or any other reporter
tag, to the probe after cell lysis, or even couple the probe
directly to azide-conjugated beads (Smith and Collins, 2015).
Originally such a strategywas explored, and a variant of probe
1, bearing an alkyne handle instead of a biotin moiety, was
created by directly activating compound 4 with an NHS ester.
This probe was coupled to Ac-Nle-SP and added to cells
expressing the NK1 receptor. Then, CuAAC was attempted
on lysates of these cells to couple this probe to either biotin- or
azide-conjugated agarose beads. In our hands, however, this
strategy was not successful. For the purpose of identifying
transmembrane receptors on living cells, no cell entrance is
required, hence it was decided to attach biotin to the probe
from the outset, resulting in probe 1.
It should be noted that probe 1 was not fully purified.
LC-MS analysis revealed the presence of some hydrolyzed
probe 5, as well as a probe product which had undergone cyclic
Fig. 8. Identification of proteins by mass spectrometry after ligand-based receptor capture. (A) Schematic view of human proteins identified by
LC-MS/MS after LRC experiments with either Gly-probe or Ac-Nle-SP-probe. (B) The amino acid sequence of the human NK1 receptor is displayed.
Peptides that were identified using LC-MS/MS after LRCwith Ac-Nle-SP-probe are colored. See Table 1 for further details (1 = blue, 2 = green, 3 = yellow,
4 = purple. 5 = green).
TABLE 1
Peptide sequences from NK1 receptor identified by mass spectrometry
Peptide sequence Total Numberof Spectra
Found in
# Samples Modifications
1 (R)LETTISTVVGAHEEEPEDGPK(A) 2 2
2 (R)YLQTQGSVYKVSR(L) 1 1
3 (K)ATPSSLDLTSNcSSR(S) 2 2 Carbamidomethyl
4 (R)YMAIIHPLQPR(L) 1 1
5 (R)YLQTQGSVYK(V) 1 1
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imide formation (6) (Supplemental Fig. S1). Whether these
by-products were formed during the analysis or whether they
were actually present in the product was not investigated,
since they were not expected to interfere with coupling of a
ligand. For ligand coupling, probe 1 was dissolved in PBS (pH
8.2) and partial hydrolysis as well as intramolecular cycliza-
tion of the active NHS ester were inevitable under these
conditions (Supplemental Fig. S3) (Lim et al., 2014; Klykov
and Weller, 2015). These probe by-products were easily
eliminated when the cells were washed before irradiation.
Indeed, when cells lacking expression of NK1 receptor were
treated with the Ac-Nle-SP-probe, no substantial background
labeling was observed (Fig. 5, right panels).
For ligand-based receptor-capture experiments to be suc-
cessful, it is important that the ligand-probe adduct binds to
the receptor(s) of interest. In this case, this was tested by using
accumulation of IP1, which is a consequence of binding of SP
and related peptides to the NK1 receptor. After binding of the
ligand-probe adduct to the receptor, it is vital that the ligand
remains associated with the receptor until the probe is
activated by UV light. Incubation of cells with Ac-Nle-SP-
probe was first performed at 37°C; however, it was soon
appreciated that the NK1 receptor rapidly (3 minutes) inter-
nalizes upon activation by its agonist SP (Garland et al., 1994).
Internalization of the NK1-SP complex is known to be linked
with dissociation and degradation of SP; therefore, it was
important to perform receptor-capture experiments at lower
temperatures, preventing internalization of the receptor
(Garland et al., 1994). That the Ac-Nle-SP-probe still bound
to the NK1 receptor at 4°C but did not result in substantial
internalization of the receptor was apparent from the micros-
copy studies. These low temperatures also slowed down the
dissociation of the ligand from the receptor. Potentially, this
may be beneficial for receptor capture, as it should keep the
probe in close proximity to the receptor. It did, however, limit
dissociation and competition of the non-crosslinked Ac-Nle-
SP-probe from the NK1 receptor in the presence of an excess of
free Ac-Nle-SP.
After initial characterization of the probe, a proof of concept
for probe 1 was provided in which Ac-Nle-SP was coupled to
this probe and used to identify the GPCR NK1 through
LC-MS/MS. This is one of the few successful examples in
which a GPCR has been identified using a universal probe and
proteomics. TRICEPS was used previously to identify the
apelin receptor; however, this probe clearly has shortcomings
with respect to the requirement for glycosylation of the
receptor (Frei et al., 2012). While we were working on the
development of these photoreactive universal probes, others
also realized the benefit of incorporating photoreactive groups
into probes targeting transmembrane receptors. Two reports
describing such probes specifically targeting GPCRs have
been published recently. In both cases, the probes were
designed on known pharmacological ligands rather than being
potentially universal. Blex et al. (2017) generated the probe
CPT-00031 based on the structure of sertindole, a well known
dopamine D2 receptor antagonist, whereas Thomas et al.
(2017) created a probe based on the structure of an active
parent compound known to bind G protein–coupled receptor
39. Akin to the probe described herein, both of these probes
also contained a 3-aryl-3-(trifluoromethyl)diazirine moiety
and a biotin group and were tested on systems overexpressing
the receptor of interest.
A major challenge in progressing studies of this nature to
true unbiased detection of genuinely novel ligand-receptor
interactions is the number of “off-target” interactions that are
identified, and including appropriate negative controls is an
important aspect of LRC experiments. In the studies using
CPT-00031 on dopamine D2 receptor–expressing HEK293
cells, a competition experiment with an excess of sertindole
was performed as a potential negative control. However, there
were over 150 proteins enriched in the noncompetition over
the competition samples (Blex et al., 2017). Although this
study did attempt to assess sensitivity by diluting transfected
cells with nontransfected control cells, there were always
other proteins identified as well as the dopamine D2 receptor.
Moreover, when diluting the transfected cells to a level in
which the target receptor was not enriched, 18 other mem-
brane proteins were enriched. Whether any of these 18 pro-
teins truly bound to sertindole was not further investigated.
Unfortunately, Thomas et al. (2017), who used a similar
competition experiment as a negative control, did not include
the full data set obtained with their LC-MS/MS experiments,
and therefore, it is hard to ascertain how many proteins were
identified in the LRC studies. It is clear, however, that there
were at least seven transmembrane receptors, including G
protein–coupled receptor 39, enriched in the noncompetition
samples (Thomas et al., 2017). In the studies reported herein,
instead of competition experiments, an LRC experiment using
Gly-probe was used as a negative control. In contrast to the
two probes discussed earlier, comparison between the Gly-
probe- and the Ac-Nle-SP-probe–treated samples resulted in
the identification of only one protein: the NK1 receptor.
Establishing that probe 1 can indeed be used to identify the
NK1 receptor as the Ac-Nle-SP–binding receptor in a test
system is an important proof of concept toward general
utilization of this probe to help identify unknown plasma-
membrane receptors for ligands of interest. Nevertheless, the
goal of developing a truly high-specificity and universal probe
for ligand-based receptor capture that can be used with
confidence in natively expressing cells and tissue remains a
substantial challenge.
Acknowledgments
We thank John Pediani for help with the confocal microscopy
experiments and Andrew Bottrill and Sharad Mistry for the perfor-
mance of the LC-MS/MS analysis.
Authorship Contributions
Participated in research design: Müskens, Ward, van de Langem-
heen, Tobin, Liskamp, Milligan.
Conducted experiments: Müskens.
Contributed new reagents or analytic tools: Müskens, Herkt.
Performed data analysis: Müskens.
Wrote or contributed to the writing of the manuscript: Müskens,
Liskamp, Milligan.
References
Anderson GW, Zimmerman JE, and Callahan FM (1963) N-hydroxysuccinimide es-
ters in peptide synthesis. J Am Chem Soc 85:3039.
Blex C, Michaelis S, Schrey AK, Furkert J, Eichhorst J, Bartho K, Gyapon Quast F,
Marais A, Hakelberg M, Gruber U, et al. (2017) Targeting G Protein-coupled re-
ceptors by capture compound mass spectrometry: a case study with sertindole.
ChemBioChem 18:1639–1649.
Chambers JM, Lindqvist LM, Webb A, Huang DCS, Savage GP, and Rizzacasa MA
(2013) Synthesis of biotinylated episilvestrol: highly selective targeting of the
translation factors eIF4AI/II. Org Lett 15:1406–1409.
Craig R and Beavis RC (2004) TANDEM: matching proteins with tandem mass
spectra. Bioinformatics 20:1466–1467.
208 Müskens et al.
 at A
SPET Journals on A
ugust 2, 2019
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
Frei AP, Jeon O-Y, Kilcher S, Moest H, Henning LM, Jost C, Plückthun A, Mercer J,
Aebersold R, Carreira EM, et al. (2012) Direct identification of ligand-receptor
interactions on living cells and tissues. Nat Biotechnol 30:997–1001.
Garcia-Recio S and Gascón P (2015) Biological and pharmacological aspects of the
NK1-receptor. BioMed Res Int 2015:495704.
Garland AM, Grady EF, Payan DG, Vigna SR, and Bunnett NW (1994) Agonist-
induced internalization of the substance P (NK1) receptor expressed in epithelial
cells. Biochem J 303:177–186.
Geurink PP, Klein T, Prely L, Paal K, Leeuwenburgh MA, Van Der Marel GA,
Kauffman HF, Overkleeft HS, and Bischoff R (2010) Design of peptide
hydroxamate-based photoreactive activity-based probes of zinc-dependent
metalloproteases. Eur J Org Chem 11:2100–2112.
Hartwig S and Hecht S (2010) Polypseudopeptides with variable stereochemistry:
synthesis via click-chemistry, postfunctionalization, and conformational behavior
in solution. Macromolecules 43:242–248.
Hatanaka Y (2015) Development and leading-edge application of innovative photo-
affinity labeling. Chem Pharm Bull (Tokyo) 63:1–12.
Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, and Gloriam DE (2017)
Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug
Discov 16:829–842.
Helbig AO, Heck AJR, and Slijper M (2010) Exploring the membrane proteome--
challenges and analytical strategies. J Proteomics 73:868–878.
Hermanson GT (2013) (Strept)avidin–biotin systems, in Bioconjugate Techniques pp
465–505, Elsevier, Boston.
Hill JR and Robertson AAB (2018) Fishing for drug targets: a focus on diazirine
photoaffinity probe synthesis. J Med Chem 61:6945–6963.
Hopkins AL and Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:
727–730.
Keller A, Nesvizhskii AI, Kolker E, and Aebersold R (2002) Empirical statistical
model to estimate the accuracy of peptide identifications made by MS/MS and
database search. Anal Chem 74:5383–5392.
Kleiner P, Heydenreuter W, Stahl M, Korotkov VS, and Sieber SA (2017) A whole
proteome inventory of background photocrosslinker binding. Angew Chem Int Ed
Engl 56:1396–1401.
Klykov O and Weller MG (2015) Quantification of N-hydroxysuccinimide and
N-hydroxysulfosuccinimide by hydrophilic interaction chromatography (HILIC).
Anal Methods 7:6443–6448.
Lenz T, Fischer JJ, and Dreger M (2011) Probing small molecule-protein interactions:
a new perspective for functional proteomics. J Proteomics 75:100–115.
Li Y, Ozment T, Wright GL, and Peterson JM (2016) Identification of putative re-
ceptors for the novel adipokine CTRP3 using ligand-receptor capture technology.
PLoS One 11:e0164593.
Li Z, Zeppa JJ, Hancock MA, McCormick JK, Doherty TM, Hendy GN, and Madrenas
J (2018) Staphylococcal superantigens use LAMA2 as a coreceptor to activate
T cells. J Immunol 200:1471–1479.
Lim CY, Owens NA, Wampler RD, Ying Y, Granger JH, Porter MD, Takahashi M,
and Shimazu K (2014) Succinimidyl ester surface chemistry: implications of the
competition between aminolysis and hydrolysis on covalent protein immobiliza-
tion. Langmuir 30:12868–12878.
Mädler S, Bich C, Touboul D, and Zenobi R (2009) Chemical cross-linking with
NHS esters: a systematic study on amino acid reactivities. J Mass Spectrom
44:694–706.
Nesvizhskii AI, Keller A, Kolker E, and Aebersold R (2003) A statistical model for
identifying proteins by tandem mass spectrometry. Anal Chem 75:4646–4658.
Overington JP, Al-Lazikani B, and Hopkins AL (2006) How many drug targets are
there? Nat Rev Drug Discov 5:993–996.
Perkins DN, Pappin DJ, Creasy DM, and Cottrell JS (1999) Probability-based protein
identification by searching sequence databases using mass spectrometry data.
Electrophoresis 20:3551–3567.
Ponda MP and Breslow JL (2016) Serum stimulation of CCR7 chemotaxis due to
coagulation factor XIIa-dependent production of high-molecular-weight kininogen
domain 5. Proc Natl Acad Sci USA 113:E7059–E7068.
Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-
Lazikani B, Hersey A, Oprea TI, et al. (2017) A comprehensive map of molecular
drug targets. Nat Rev Drug Discov 16:19–34.
Savas JN, Stein BD, Wu CC, and Yates JR III (2011) Mass spectrometry accelerates
membrane protein analysis. Trends Biochem Sci 36:388–396.
Schirle M and Jenkins JL (2016) Identifying compound efficacy targets in phenotypic
drug discovery. Drug Discov Today 21:82–89.
Searle BC (2010) Scaffold: a bioinformatic tool for validating MS/MS-based proteomic
studies. Proteomics 10:1265–1269.
Smith E and Collins I (2015) Photoaffinity labeling in target- and binding-site
identification. Future Med Chem 7:159–183.
Sobotzki N, Schafroth MA, Rudnicka A, Koetemann A, Marty F, Goetze S, Yamauchi
Y, Carreira EM, and Wollscheid B (2018) HATRIC-based identification of receptors
for orphan ligands. Nat Commun 9:1519.
Sumranjit J and Chung SJ (2013) Recent advances in target characterization and
identification by photoaffinity probes. Molecules 18:10425–10451.
Thomas JR, Brittain SM, Lipps J, Llamas L, Jain RK, and Schirle M (2017) A pho-
toaffinity labeling-based chemoproteomics strategy for unbiased target deconvo-
lution of small molecule drug candidates. Methods Mol Biol 1647:1–18.
Tremblay T-L and Hill JJ (2017) Biotin-transfer from a trifunctional crosslinker for
identification of cell surface receptors of soluble protein ligands. Sci Rep 7:46574.
UniProt Consortium (2010) The universal protein resource (UniProt) in 2010.Nucleic
Acids Res 38:D142–D148.
von Stetten D, Noirclerc-Savoye M, Goedhart J, Gadella TWJ Jr., and Royant A (2012)
Structure of a fluorescent protein from Aequorea victoria bearing the obligate-monomer
mutation A206K. Acta Crystallogr Sect F Struct Biol Cryst Commun 68:878–882.
Vuckovic D, Dagley LF, Purcell AW, and Emili A (2013) Membrane proteomics by
high performance liquid chromatography-tandem mass spectrometry: analytical
approaches and challenges. Proteomics 13:404–423.
Ward RJ, Pediani JD, and Milligan G (2011) Heteromultimerization of cannabinoid
CB(1) receptor and orexin OX(1) receptor generates a unique complex in which
both protomers are regulated by orexin A. J Biol Chem 286:37414–37428.
Wright GJ (2009) Signal initiation in biological systems: the properties and detection
of transient extracellular protein interactions. Mol Biosyst 5:1405–1412.
Address correspondence to: Graeme Milligan, Wolfson Link Building 253,
University Avenue, University of Glasgow, Glasgow G12 8QQ, UK. E-mail:
Graeme.Milligan@glasgow.ac.uk; or Rob Liskamp, Joseph Black Building,
University Avenue, University of Glasgow, Glasgow G12 8QQ, UK. E-mail:
Robert.Liskamp@glasgow.ac.uk
A Ligand-Based Receptor-Capture Probe Targeting GPCRs 209
 at A
SPET Journals on A
ugust 2, 2019
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
